Does tDCS is Effective in the Prophylactic Treatment of Migraine
NCT ID: NCT01886274
Last Updated: 2014-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
36 participants
INTERVENTIONAL
2012-10-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimized tDCS for the Treatment of Migraine
NCT02562222
tDCS for the Treatment of Migraine
NCT02562196
Transcranial Direct Current Simulation in Chronic Migraine
NCT02817139
Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache
NCT01752439
Comparison Between Transcranial Stimulation Protocols With Continuous Current in the Chronic Migraine
NCT03414203
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
tDCS
The experimental group received tDCS to the occipital cortex in 12 sessions, 3 days per week.
Transcranial direct current stimulation
tDCS involves application of very low amplitude direct current via surface scalp electrodes. The applied current modifies the transmembrane neuronal potential and thus influences the level of excitability. Depending on the polarity of active electrodes tDCS can increase or decrease the cortical excitability. The cathodal tDCS decrease the excitability, in this study a constant current of 2 mA intensity was applied for 20 min.
control
The control group received sham stimulation to the occipital cortex in 12 sessions, 3 days per week.
Transcranial direct current stimulation
tDCS involves application of very low amplitude direct current via surface scalp electrodes. The applied current modifies the transmembrane neuronal potential and thus influences the level of excitability. Depending on the polarity of active electrodes tDCS can increase or decrease the cortical excitability. The cathodal tDCS decrease the excitability, in this study a constant current of 2 mA intensity was applied for 20 min.
healthy subjects
This group was submitted to one evaluation session of cortical excitability.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial direct current stimulation
tDCS involves application of very low amplitude direct current via surface scalp electrodes. The applied current modifies the transmembrane neuronal potential and thus influences the level of excitability. Depending on the polarity of active electrodes tDCS can increase or decrease the cortical excitability. The cathodal tDCS decrease the excitability, in this study a constant current of 2 mA intensity was applied for 20 min.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gender: male and female
* Diagnosis must meet the 2004 IHS criteria for migraine without aura and migraine with aura
* Duration of the disease must be at least 12 months
* Patients had no preventative medication consistently for at least six months prior to study initiation.
* Age must be between 18 to 40 years
* Gender: male and female
* Individuals who have not filed headache crisis in the last year assessed according to the 2004 IHS criteria
Exclusion Criteria
* Individuals with clinical evidence of brain injury
* Metallic implant head
* Pacemaker
* History of seizure and chronic pain associated with other pathologies
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Pernambuco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kátia Monte-Silva
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Applied Neuroscience Laboratory-LANA
Recife, Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Migraine_tDCS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.